NCT04629729 2026-03-19FT819 in Subjects With B-cell MalignanciesFate TherapeuticsPhase 1 Active not recruiting54 enrolled
NCT04155710 2025-12-24Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLLIovance Biotherapeutics, Inc.Phase 1 Completed7 enrolled